Patient adherence in COPD.

Thorax
Jean Bourbeau, S J Bartlett

Abstract

Patient adherence to treatment in chronic obstructive pulmonary disease (COPD) is essential to optimise disease management. As with other chronic diseases, poor adherence is common and results in increased rates of morbidity, healthcare expenditures, hospitalisations and possibly mortality, as well as unnecessary escalation of therapy and reduced quality of life. Examples include overuse, underuse, and alteration of schedule and doses of medication, continued smoking and lack of exercise. Adherence is affected by patients' perception of their disease, type of treatment or medication, the quality of patient provider communication and the social environment. Patients are more likely to adhere to treatment when they believe it will improve disease management or control, or anticipate serious consequences related to non-adherence. Providers play a critical role in helping patients understand the nature of the disease, potential benefits of treatment, addressing concerns regarding potential adverse effects and events, and encouraging patients to develop self-management skills. For clinicians, it is important to explore patients' beliefs and concerns about the safety and benefits of the treatment, as many patients harbour unspoken fe...Continue Reading

Citations

Jan 6, 2010·Journal of General Internal Medicine·Jessica P HwangMaria E Suarez-Almazor
Oct 17, 2012·Australian Journal of Primary Health·Sue E KirbyMark F Harris
Oct 11, 2012·International Journal of Telemedicine and Applications·Jonathan TangTrevor Russell
Jun 1, 2013·The European Respiratory Journal·Eric D BatemanDonald Banerji
Sep 24, 2013·Respiratory Research·Fulvio BraidoGiorgio Walter Canonica
Mar 10, 2010·BMC Pulmonary Medicine·Gregory FeldmanUNKNOWN INLIGHT 1 study group
Jan 26, 2011·BMC Pulmonary Medicine·Pilar Barnestein-FonsecaFrancisca Leiva-Fernández
Feb 15, 2011·BMC Pulmonary Medicine·Elizabeth ArnoldElizabeth Walker
Dec 12, 2012·BMC Pulmonary Medicine·Helen ArievichDonald Banerji
Nov 3, 2011·ClinicoEconomics and Outcomes Research : CEOR·York ZoellnerAndrea Gili Marco
Sep 22, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Beatrix BalintUNKNOWN INSURE Study Investigators
Dec 31, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Suzanne C Lareau, Barbara P Yawn
Mar 17, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Masaya TakemuraMotonari Fukui
Mar 16, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Marcos Ribeiro, Kenneth R Chapman
Oct 18, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Eugene R BleeckerBenjamin Kramer
Nov 10, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Frits M E FranssenEmiel F M Wouters
Mar 22, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Abebaw M YohannesNicola A Hanania
Aug 1, 2012·International Journal of Chronic Obstructive Pulmonary Disease·E Haydn WaltersRichard Wood-Baker
Aug 14, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Barbara P YawnRick Hodder
Aug 1, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Pere Almagro, Alejandra Castro
Nov 3, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Roland Buhl, Donald Banerji
May 10, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Gary T FergusonLeonard J Dunn
Oct 2, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Erminia RidoloCristoforo Incorvaia
Aug 5, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Jutta Beier, Kai M Beeh
Mar 6, 2013·Journal of Multidisciplinary Healthcare·Pamela Spencer, Nicola A Hanania
Dec 6, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Susannah McLeanAziz Sheikh
Oct 7, 2011·Annals of Thoracic Medicine·C Incorvaia, G G Riario-Sforza
May 9, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Debra J Reid, Alexa A Carlson
Mar 14, 2014·BMC Pulmonary Medicine·Dave SinghUNKNOWN FUTURE (Foster Upgrades TherapeUtic care in REspiratory disease) study group
Nov 21, 2013·Tijdschrift voor gerontologie en geriatrie·F A H M CleutjensE F M Wouters
Apr 9, 2013·Primary Health Care Research & Development·Onur TuranOya Itil
Feb 22, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Andreas von LeupoldtThomas Ritz
Nov 17, 2010·International Journal of Behavioral Medicine·Maarten J FischerAdrian A Kaptein
May 2, 2014·Journal of Pain and Symptom Management·Rebecca T DislerPatricia M Davidson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.